Skip to main content
Jonathan Silverberg, MD, Dermatology, Washington, DC

JonathanIanSilverbergMD

Dermatology Washington, DC

Associate Professor of Dermatology, George Washington University School of Medicine and Health Sciences

Dr. Silverberg is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Silverberg's full profile

Already have an account?

Summary

  • Dr. Jonathan Silverberg is a dermatologist in Washington, DC and is affiliated with George Washington University School of Medicine and Health Sciences. He received his medical degree from State University of New York Downstate Medical Center College of Medicine and has been in practice 8 years. He is experienced in general dermatology, atopic dermatitis, contact dermatitis, allergic contact dermatitis, and eczema.

Education & Training

  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineResidency, Dermatology, 2010 - 2013
  • SUNY Health Science Center at Brooklyn
    SUNY Health Science Center at BrooklynInternship, Internal Medicine, 2009 - 2010
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2009

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2019 - 2021
  • DC State Medical License
    DC State Medical License 2019 - 2022
  • IL State Medical License
    IL State Medical License 2013 - 2020
  • OR State Medical License
    OR State Medical License 2012 - Present
  • NY State Medical License
    NY State Medical License 2012 - 2014
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Journal Articles

  • Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic Dermatitis  
    Jonathan I Silverberg, Eric L Simpson, Hernan Valdez, JAMA Dermatology
  • Dupilumab Provides Important Clinical Benefits to Patients with Atopic Dermatitis Who Do Not Achieve Clear or Almost Clear Skin According to the Investigator's Global ...  
    J I Silverberg, The British Journal of Dermatology
  • Inpatient Burden of Juvenile Dermatomyositis Among Children in the United States  
    Michael C Kwa, Jonathan I Silverberg, BioMed Central
  • Join now to see all

Lectures

  • Exploring the Association Between Parental Psychiatric Disease and Childhood Atopic Dermatitis: A Matched Case‐Control Study 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019

Authored Content

  • Efficacy and Safety of Abrocitinib in Patients with Moderate-to-Severe Atopic DermatitisJune 2020

Press Mentions

  • Atopic Dermatitis: New Topical Agent, Durable Results with Orals
    Atopic Dermatitis: New Topical Agent, Durable Results with OralsNovember 2nd, 2020
  • FDA Grants Priority Review for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and up with Moderate to Severe AD
    FDA Grants Priority Review for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and up with Moderate to Severe ADOctober 27th, 2020
  • Disease Burden High for Adolescents with Atopic Dermatitis
    Disease Burden High for Adolescents with Atopic DermatitisFebruary 5th, 2020
  • Join now to see all